RIFAMOR®
Capsule, hard, 300mg
RxActive license
Active substance (INN)
rifampicin
Pharmaceutical form
Pharmaceutical formCapsule, hard
Strength300mg
PackagingUkupno 16 kapsula, tvrdih u blisteru (2x8) u kartonskoj kutiji
ManufacturerGalenika a.d. Beograd, Serbia
Therapeutic groupAnti-infectives for systemic use (J04AB02)
Marketing authorization holder"GLK PHARMA" DRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU, PODGORICA
Authorization dateNovember 3, 2021
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026